• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
UTHR

UTHR

United Therapeutics Corporation

NASDAQHealthcareBiotechnologyUS

USD549.47

+9.42 (+1.74%)

Rating:A-

Company Profile

CEO

Martine A. Rothblatt

IPO Date

1999-06-17

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$543.50

Prev. Close

$540.05

Day Low

$541.10

Day High

$551.89

52W Low

$272.12

52W High

$609.35

Market Cap

$23.32B

Volume

0.31M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

10

Avg Positive

9.3%

Avg Negative

2.6%

Avg Neutral

88.8%

News Feed

United Therapeutics Corporation To Report Second Quarter 2021 Financial Results Before The Market Opens On Wednesday, August 4, 2021

PRNewsWire·7/28/2021·↓ negative

United Therapeutics Announces The Lancet Respiratory Medicine Publication Of Post-Hoc Analysis Of FVC Change From The Tyvaso® INCREASE Study

PRNewsWire·6/30/2021·↓ negative

United Therapeutics (UTHR) Tyvaso DPI Gets FDA's Priority Tag

Zacks Investment Research·6/17/2021·↑ positive

United Therapeutics Announces FDA Acceptance of Tyvaso DPI™ New Drug Application For Priority Review

PRNewsWire·6/16/2021·↓ negative

United Therapeutics Pursues New Claims For Trade Secret Misappropriation Against Liquidia

PRNewsWire·6/7/2021·↓ negative

United Therapeutics (UTHR) Begins TETON Study on Tyvaso in IPF

Zacks Investment Research·6/4/2021·↑ positive

United Therapeutics Announces First Patient Enrolled In Phase 3 TETON Study Of Tyvaso In Patients With Idiopathic Pulmonary Fibrosis

PRNewsWire·6/3/2021·↓ negative

United Therapeutics Corporation To Present At The Jefferies Virtual Healthcare Conference

PRNewsWire·5/25/2021·↓ negative

United Therapeutics (UTHR) Lags Q1 Earnings Estimates

Zacks Investment Research·5/5/2021·↑ positive

United Therapeutics Corporation Reports First Quarter 2021 Financial Results

PRNewsWire·5/5/2021·↓ negative